Table 2.
Data | Drug–disease corpus | Drug–phenotype corpus | Total |
---|---|---|---|
No. articles reviewed | 78 263 | 10 366 | 88 629 |
No. articles curateda | 51 884 | 9 646 | 61 530 |
No. articles rejected | 26 379 | 720 | 27 099 |
No. total interactions | 183 849 | 70 324 | 254 173 |
No. chemical–disease interactions | 145 366 | 6 807 | 152 173 |
No. chemical–gene interactions | 32 539 | 26 033 | 58 572 |
No. gene–disease interactions | 4 603 | 742 | 5 345 |
No. phenotype interactions | 1 341b | 36 742 | 38 083 |
Average no. interactions per curated article | 3.5 | 7.3 | n/a |
Average no. chemicals per curated article | 1.7 | 2.3 | n/a |
Average no. diseases per curated article | 2.0 | 0.5 | n/a |
Average no. genes per curated article | 0.5 | 1.9 | n/a |
Average no. phenotypes per curated article | <0.0b | 1.6 | n/a |
Average no. anatomy terms per curated article | <0.0b | 1.7 | n/a |
Average no. taxa per curated article | 1.0 | 1.0 | n/a |
aabstract curation whenever possible; full text was examined if necessary to resolve issues.
bcurated from 401 drug–disease articles during transitional period to drug–phenotype phase.
n/a, not applicable.